Medi-Caps appoints new CFO, adds daughter-in-law as Whole Time Director

Promoter family joins the boardManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹26.55

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-2.1% vs market

Pharmaceuticals peers, median of 168sector+0.3%-2.4% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.1+0.0-2.1+0.3-2.4

Next day

+1.2-0.0+1.3+0.7+0.5

-0.6-0.2-0.4+0.6-1.2

+0.9+0.2+0.8+0.4+0.6

-0.9+0.3-1.2+1.2-2.1

+3.4+0.4+3.0+0.2+3.2

—+0.9—+0.2—

15d

—+1.6—+1.1—

—+2.0—+2.4—

—+0.6—+1.6—

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved three changes: re-appointment of Mr. Alok K. Garg as Chairman cum Managing Director for 3 years from Sept 1, 2026; appointment of Mr. Akshit Garg (MBA from Australia, 8 years finance experience) as CFO and KMP from Aug 7, 2026; and appointment of Mrs. Saloni Garg, daughter-in-law of the CMD, as Additional and Whole Time Woman Director for 3 years. Subject to shareholder approval at the 43rd AGM.

Likely market impact

Family succession underway with daughter-in-law and likely family member joining top roles. CMD re-appointed for continuity through 2029.